SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-23-011904
Filing Date
2023-07-17
Accepted
2023-07-17 07:15:10
Documents
14
Period of Report
2023-07-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tmb-20230714x8k.htm   iXBRL 8-K 42504
2 EX-99.1 tmb-20230714xex99d1.htm EX-99.1 24407
3 GRAPHIC tmb-20230714xex99d1001.jpg GRAPHIC 11583
  Complete submission text file 0001558370-23-011904.txt   210727

Data Files

Seq Description Document Type Size
4 EX-101.SCH tmb-20230714.xsd EX-101.SCH 3112
5 EX-101.LAB tmb-20230714_lab.xml EX-101.LAB 15918
6 EX-101.PRE tmb-20230714_pre.xml EX-101.PRE 10044
8 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20230714x8k_htm.xml XML 4848
Mailing Address 44 MILTON AVENUE ALPHARETTA GA 30009
Business Address 44 MILTON AVENUE ALPHARETTA GA 30009 8666208655
Virios Therapeutics, Inc. (Filer) CIK: 0001818844 (see all company filings)

IRS No.: 854314201 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39811 | Film No.: 231090502
SIC: 2834 Pharmaceutical Preparations